论文部分内容阅读
国食药监安[2008]319号2008年06月27日发布各省、自治区、直辖市食品药品监督管理局(药品监督管理局):2001年,盐酸麻黄碱滴鼻液被遴选为非处方药。根据《反兴奋剂条例》和《关于开展处方药与非处方药转换评价工作的通知》(国食药监安[2004]101号)要求,现决定将盐酸麻黄碱滴鼻液由非处方药转换为处方药,并就有关事宜通知如下:一、2008年7月31日后,盐酸麻黄碱滴鼻液标签和
State Food and Drug Administration [2008] No. 319 June 27, 2008 Released provinces, autonomous regions and municipalities Food and Drug Administration (Drug Administration): In 2001, ephedrine hydrochloride nasal drops were selected as non-prescription drugs. Pursuant to the Anti-Doping Regulations and the Notice Concerning the Evaluation of the Conversion of Prescription Drugs and Nonprescription Drugs (Guojianyao’an [2004] No.101), it was decided to convert ephedrine hydrochloride nasal drops from over-the-counter medicines to prescription medicines and Notices on the matter as follows: First, after July 31, 2008, ephedrine hydrochloride nasal drops label and